…all entering early in-human clinical trials to treat a range of diseases. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts….
…partner for a wide range of targeted therapies.” KO-2806 is a next-generation inhibitor of farnesyl transferase designed to improve upon potency, pharmacokinetic and physicochemical properties of earlier FTI drug candidates….
…First patient dosed with antibody drug conjugate for HER2+ tumours Iksuda Therapeutics has dosed the first patient in a Phase I trial of antibody drug conjugate (ADC) IKS014 in patients…
…between Lu Rahman and Frederic Triebel, CSO, Immutep, who also discovered LAG-3. You can also find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. Listen here:…
…of most influential companies in the drug discovery space, pushing antibody discovery programmes forward. Qasim Ahmad Muaiad Kittaneh Andreas Dreps Joseph Peterson Raffi Tonikian The presentations…
…mix-and-read assays. Learn the background and details of example data, within the following applications: Cell health Secreted proteins Cell line development Biologics discovery Immune cell models Cell therapy Download now….
…currently available until 31 October 2023. New for this year will be the SLAS Ignite Theater, curated by Drug Discovery World and sponsored by Integra Biosciences and Hamamatsu. Taking place…
…novel predictive biomarkers. As one key element for PanOmics-driven drug discovery we have established leading high-throughput and high-resolution transcriptomics data generation capabilities. Transcriptomics, an unbiased approach to quantify mRNAs in…
…Barnett Rosanna Zhang What you will learn: How advanced technologies are proving beneficial to drug discovery and development The current unmet need within drug…
Iksuda Therapeutics has dosed the first patient in a Phase I trial of antibody drug conjugate (ADC) IKS014 in patients with advanced solid tumours that express HER2. This follows positive…
bit.bio has launched the first offering from its new product range ioCRISPR-Ready Cells, which allow research and drug discovery scientists to knockout any gene of interest in glutamatergic neurons. CRISPR-Ready…
…news round-up this week highlights the latest developments in oncology drug discovery. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts….
…monoclonal antibody antiretroviral therapy (ART) for the treatment of heavily treatment-experienced adults with multidrug-resistant (MDR) HIV-1 infection failing their current antiretroviral regimen. The TMB-302 study, conducted in partnership with TaiMed…
